Scientists in Japan have identified a key mechanism in the body’s rapid detection of viral RNA, a crucial first step in activating the immune system. The research, published in Molecular Cell in January 2026, details how the protein LGP2 assists the receptor MDA5 in recognizing viral genetic material, even when it’s present in short fragments.
The innate immune system is the body’s initial defense against pathogens. When a virus infects a cell, it releases double-stranded RNA (dsRNA) as it replicates. Cells contain receptors that recognize this dsRNA as a signal of infection. MDA5 is a primary receptor responsible for this detection, triggering a cascade of events that ultimately lead to the production of antiviral proteins. However, MDA5 functions most effectively with longer strands of dsRNA.
Researchers at the Institute of Integrated Research at Science Tokyo, led by Associate Professor Kazuki Kato, investigated how the body overcomes this limitation. Their work, conducted in collaboration with Professor Osamu Nureki and graduate student Nina Kurihara from the University of Tokyo, focused on the role of LGP2, a protein known to interact with both MDA5 and viral RNA.
The team discovered that LGP2 is particularly key in recognizing shorter RNA molecules. Using cryo-electron microscopy and high-speed atomic force microscopy, they observed LGP2 binding to the ends of a dsRNA strand and then “translocating” – moving along the RNA using energy from ATP. As LGP2 moves, it recruits MDA5 molecules, helping them assemble into filament-like structures. Kato likened the process to threading beads, with the RNA acting as the string and LGP2 guiding the MDA5 molecules into place.
This process isn’t simply about bringing MDA5 to the RNA; the researchers found that LGP2 promotes the formation of small clusters of MDA5 filaments. These clusters then enhance the activation of MAVS, a signaling protein vital for amplifying the antiviral response within cells. According to Kato, the study “clarifies the precise mechanisms by which LGP2 recognizes viral RNA and cooperates with MDA5 to activate immune responses.”
Recent research has highlighted the importance of understanding these innate immune responses. A study published in Nature found that a loss-of-function variant of the ADAR enzyme, which typically edits RNA, can activate the innate immune system and contribute to bowel inflammation. This underscores the delicate balance required for proper immune function and the potential consequences of disruptions in RNA recognition pathways. Research published in Science suggests that recognizing dsRNA doesn’t necessarily trigger cellular inflammation, adding nuance to the understanding of these immune responses.
Kato suggests that a deeper understanding of the LGP2-MDA5 interaction could have implications for the development of antiviral therapies and RNA-based medical technologies, including mRNA vaccines. “These findings deepen our understanding of viral RNA recognition and are expected to contribute to the design of safer and more effective mRNA vaccines,” he stated.
